Literature DB >> 9030191

Characterization of human apolipoprotein A-I expressed in Escherichia coli.

J Bergeron1, P G Frank, F Emmanuel, M Latta, Y Zhao, D L Sparks, E Rassart, P Denèfle, Y L Marcel.   

Abstract

Human apolipoprotein A-I (apoA-I), with an additional N-terminal extension (Met-Arg-Gly-Ser-(His)6-Met) (His-apoA-I), has been produced in Escherichia coli with a final yield after purification of 10 mg protein/1 of culture medium. We have characterized the conformation and structural properties of His-apoA-I in lipid-free form, and in reconstituted lipoproteins containing two apoA-I per particle (Lp2A-I) by both immunochemical and physicochemical techniques. The lipid-free forms of the two proteins present very similar secondary structure and stability, and have also very similar kinetics of association with dimyristoyl phosphatidylcholine. His-apoA-I and native apoA-I can be complexed with 1-palmitoyl-2-oleoyl phosphatidylcholine (POPC) to form similar, stable, either discoidal or spherical (sonicated) Lp2A-I particles. Lipid-bound native apoA-I and His-apoA-I showed very similar alpha-helical content (69% and 66%, respectively in discoidal Lp2A-I and 54% and 51%, respectively in spherical Lp2A-I). The conformation of His-apoA-I in lipid-free form and in discoidal or spherical Lp2A-I has also been shown to be similar to native apoA-I by immunochemical measurements using 13 monoclonal antibodies recognizing distinct apoA-I epitopes. In the free protein and in reconstituted Lp2A-I, the N-terminal has no effect on the affinity of any of the monoclonal antibodies and minimal effect on immunoreactivity values. Small differences in the exposure of some apoA-I epitopes are evident on discoidal particles, while no difference is apparent in the expression of any epitope of apoA-I on spherical Lp2A-I. The presence of the N-terminal extension also has no effect on the reaction of LCAT with the discoidal Lp2A-I or on the ability of complexes to promote cholesterol efflux from fibroblasts in culture. In conclusion, we show that His-apoA-I expressed in E. coli exhibits similar physicochemical properties to native apoA-I and is also identical to the native protein in its ability to interact with phospholipids and to promote cholesterol esterification and cellular cholesterol efflux.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030191     DOI: 10.1016/s0005-2760(96)00136-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Purification of recombinant apolipoproteins A-I and A-IV and efficient affinity tag cleavage by tobacco etch virus protease.

Authors:  Matthew R Tubb; Loren E Smith; W Sean Davidson
Journal:  J Lipid Res       Date:  2009-03-24       Impact factor: 5.922

2.  Expression of the C-terminal domain of human apolipoprotein A-I using a chimeric apolipoprotein.

Authors:  Daniel E Sallee; James V C Horn; Lukas A Fuentes; Paul M M Weers
Journal:  Protein Expr Purif       Date:  2017-06-15       Impact factor: 1.650

3.  A gel-based method for purification of apolipoprotein A-I from small volumes of plasma.

Authors:  Rachel J Brace; Brie Sorrenson; Dmitri Sviridov; Sally P A McCormick
Journal:  J Lipid Res       Date:  2010-07-27       Impact factor: 5.922

4.  Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation.

Authors:  Paul M M Weers; Arti B Patel; Leon C-P Wan; Emmanuel Guigard; Cyril M Kay; Anouar Hafiane; Ruth McPherson; Yves L Marcel; Robert S Kiss
Journal:  J Lipid Res       Date:  2010-09-30       Impact factor: 5.922

5.  Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins in vitro.

Authors:  Ying Yan; Shulai Lu; Shaoyou Jia; Qingzhe Dong; Lei Wang; Yunlong Wang
Journal:  Biosci Rep       Date:  2019-05-17       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.